![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Safety and Efficacy of Velpatasvir, Sofosbuvir and Voxilaprevir-based Regimens for the Treatment
of HCV Genotype 1-6: Results of the HCV-TARGET Study
|
|
|
AASLD 2019 Nov 8-12 Boston
Reported by Jules Levin
Zeuzem S, Sulkowski MS, Lim JK, Morelli GJ, Khalili M, Ben-Ari Z, Park JS, Reddy RK, Shiffman ML, Dong M, Vainorius M, Fried MW, Nelson DR, Terrault N
![1113191](../images/111319/111319-15/1113191.gif)
![1113192](../images/111319/111319-15/1113192.gif)
![1113193](../images/111319/111319-15/1113193.gif)
![1113194](../images/111319/111319-15/1113194.gif)
![1113195](../images/111319/111319-15/1113195.gif)
![1113196](../images/111319/111319-15/1113196.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|